Search Results
Sep 24, 2026, 17:39 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in DNOW Inc. of Class Action Lawsuit and Upcoming Deadlines - DNOW
[Click here for information about joining the class action]A Complaint has been filed on behalf of all investors who held DNOW common stock as of the August 5, 2025 record date and were thus entitled to vote at DNOW's September 9, 2025 special
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Pentair plc of Class Action Lawsuit and Upcoming Deadlines - PNR
Chief Financial Officer Nicholas Brazis, "to pursue another opportunity at a private company." On this news, Pentair's stock price fell $11.35 per share, or 15%, to close at $64.33 per share on July 15, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in TruGolf Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - TRUG
[Click here for information about joining the class action]A class action Complaint has been filed on behalf of investors in TruGolf Class A common stock, alleging that Defendants made materially false and/or misleading statements and/or failed to disclose
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - CAPR
$12.70 per share, or 64%, to close at $7.00 per share on July 27, 2026.Then, on July 29, 2026, the AdCom met to discuss the Deramiocel BLA. The next day, Medscape reported that the panel relied on SAP version 1.1 as the "prespecified plan" and, in a non-binding 9-3 vote, the panel "concluded that
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Alarum Technologies Ltd. of Class Action Lawsuit and Upcoming Deadlines - ALAR
subsidiary] NetNut residential proxy operator and the Popa botnet." On this news, the price of Alarum's American Depositary Receipts ("ADRs") fell $2.67 per ADR, or 20.8%, to close at $6.35 per ADR on July 2, 2026. Then, on July 2, 2026, during post-market hours, Bloomberg reported that
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Bloom Energy Corporation of Class Action Lawsuit and Upcoming Deadlines - BE
here for information about joining the class action]On July 8, 2026, Hunterbrook Media published a report entitled "Bloom's Big Lie," which alleged, among other things, that "Bloom is, in fact, reliant on Chinese scandium, according to global trade data, Chinese corporate
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Rackspace Technology, Inc. of Class Action Lawsuit and Upcoming Deadlines - RXT
[Click here for information about joining the class action]On July 9, 2026, Rackspace published second quarter 2026 financial results and "a strategic and financial update on its transition to becoming the operator of the full enterprise AI stack." The Company revealed
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Blaize Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - BZAI
[Click here for information about joining the class action]On April 28, 2026, Pelican Way Research published a short report alleging that Blaize had "artificially boosted [its] share price by engaging in a bogus
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Wise Group plc of Class Action Lawsuit and Upcoming Deadlines - WSE
criminal court." On this news, Wise's stock price fell $0.67 per share, or 5.24%, to close at $12.10 per share on June 1, 2026. The following day, Wise's stock price fell another $0.56 per share, or 4.63%, to close at $11.54 per share on June 2, 2026. Then, on July 24, 2026, The Wall
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Alibaba Group Holding Limited of Class Action Lawsuit and Upcoming Deadlines - BABA
Chinese Ministry of Industry and Information Technology. On this news, Alibaba's American Depositary Receipt ("ADR") price fell $4.69 per ADR, or 39%, over two trading days, to close at $115.38 per ADR on June 10, 2026. Then, on June 24, 2026, media outlets reported that Anthropic has accused
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Park Ha Biological Technology Co., Ltd. of Class Action Lawsuit and Upcoming Deadlines - BYAH
immediately after the Company's initial public offering ("IPO"). Park Ha's stock price increased from its IPO price of $4.00 to an all-time high of $41.49 on July 7, 2025, despite the absence of any material corporate developments or legitimate business prospects to justify such an enormous spike. Investigations
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in iTonic Holdings Ltd (f/k/a Pheton Holdings Ltd) of Class Action Lawsuit and Upcoming Deadlines - ITOC
[Click here for information about joining the class action]A Complaint has been filed on behalf of purchasers or acquirers of the Company's Class A ordinary shares, alleging that certain of the Company's officers and directors, its auditor
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors - AARD
steps." On this news, Aardvark's stock price fell $7.02 per share, or 56.2%, to close at $5.47 per share on March 2, 2026.Then, on May 14, 2026, Aardvark issued a press release "announc[ing] that the U.S. Food and Drug Administration (FDA) has placed a full clinical hold on its investigational
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Datavault AI Inc. and Certain Officers - DVLT
times.The truth began to emerge on October 31, 2025, when Wolfpack Research published a short report on Datavault AI (the "Wolfpack Report"). The Wolfpack Report alleged, among other things, that Datavault AI was a "stock promotion" that relied on misleading press releases and "empty
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Fractyl Health, Inc. and Certain Officers - GUTS
Fractyl's stock price fell $1.245 per share, or 68.03%, to close at $0.585 per share on January 29, 2026.The same day, during post-market hours, Canaccord Genuity issued a report on Fractyl, providing additional color on the site-specific issue identified by Defendant Rajagopalan. Specifically, the
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces the Filing of a Class Action Against AST SpaceMobile, Inc. and Certain Officers - ASTS
reported sale price of AST SpaceMobile's Class A common stock on February 11, 2026."Following these disclosures, AST's Class A common stock price fell $14.70 per share, or 15.17%, to close at $82.22 per share on February 12, 2026. Then, on July 15, 2026, AST issued a press release "announc[ing]
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces the Filing of a Class Action Against AppLovin Corporation and Certain Officers - APP
Accordingly, based on a "slower initial GA ramp", Bank of America Securities lowered its expectations of AppLovin's annual revenue.Following publication of the note, AppLovin's stock price fell $64.13 per share, or 12.65%, to close at $442.85 per share on July 13, 2026.Then, on August 5, 2026,
More news about: Pomerantz LLP
Sep 24, 2026, 17:39 ET Pomerantz Law Firm Announces The Filing of a Class Action Against Celsius Holdings, Inc. and Certain Officers - CELH
response, inter alia, "our policy is not to market or sample to anyone under 18".On this news, Celsius's stock price fell $1.52 per share, or 4.18%, to close at $34.86 on April 10, 2026.Then, on June 4, 2026, Texas Attorney General Ken Paxton ("Paxton") announced an investigation into
More news about: Pomerantz LLP
Sep 24, 2026, 17:37 ET Bluerock Acquisition Corp. II Announces Pricing of $150 Million Initial Public Offering
initial public offering of 15,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Global Market ("Nasdaq") and are expected to trade under the ticker symbol "BRRKU" beginning on September 25, 2026. Each unit consists of one Class A ordinary share and one-half of one redeemable
More news about: Bluerock Acquisition Corp. II
Sep 24, 2026, 17:35 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Lincoln Educational Services Corp. of Class Action Lawsuit and Upcoming Deadlines - LINC
growing 9%, "as fewer enrolled students than expected attended the first day of class." On this news, Lincoln Educational's stock price fell $10.22 per share, or 24.93%, to close at $30.77 per share on August 10, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
2 mg aflibercept (Regeneron Pharmaceuticals' (REGN) Eylea) was not met in the entire dataset. On this news, EyePoint's stock price fell $9.88 per share, or 66.98%, to close at $4.87 per share on August 17, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Stryker Corp. - SYK
of 2026, in fact remained unresolved and was now expected to persist into the fourth quarter. On this news, Stryker's stock price fell $26.70 per share, or 8.81%, to close at $276.43 per share on September 8, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ServiceTitan, Inc. - TTAN
this fiscal year, which, of course, also flows through to professional services gross margin."On this news, ServiceTitan's stock price fell $24.46 per share, or 29.98%, to close at $57.12 per share on September 9, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc. - AZTA
action]On August 24, 2026, Azenta issued a press release announcing the resignation of John Marotta from his roles as Chief Executive Officer and as a director of the Company. On this news, Azenta's stock price fell $4.52 per share, or 12.09%, to close at $32.88 per share on August 24, 2026.Pomerantz
More news about: Pomerantz LLP
Sep 24, 2026, 17:34 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of lululemon athletica inc. - LULU
social-media commentary, softer-than-planned new-product launches, and weaker store traffic. On this news, lululemon's stock price fell $21.16 per share, or 17.38%, to close at $100.61 per share on September 4, 2026.Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris,
More news about: Pomerantz LLP